梅花生物：拟回购不低于3500万元且不超过5000万元公司股份

Group 1 - The company, Meihua Biological, announced a share repurchase plan with a total fund of no less than 35 million RMB and no more than 50 million RMB, aimed at implementing an employee stock ownership plan or equity incentive [1] - The repurchase price will not exceed 15 RMB per share, with the specific price determined by the board based on market conditions and the company's financial status [1] - The repurchase period is set for a maximum of 12 months from the date of board approval [1] Group 2 - For the year 2024, the company's revenue composition is as follows: 97.34% from biological fermentation, 1.9% from pharmaceutical health, and 0.76% from other businesses [1] - The current market capitalization of Meihua Biological is 28.7 billion RMB [2]